L-2-oxothiazolidine-4-carboxylic acids slow down dialysate-induced senescence in human peritoneal mesothelial cells

J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.08. Epub 2019 Feb 21.

Abstract

Peritoneal dialysis induces an intraperitoneal inflammatory reaction, which in the long term may cause deterioration of the peritoneal structure and function as the dialysis membrane. We studied the effect of the overnight effluent dialysate from patients on chronic peritoneal dialysis on aging of the human peritoneal mesothelial cells in an in vitro model of replicative cellular senescence. In the control group cells were cultured in the standard medium and in the studied groups in culture medium mixed 1:1 v/v with the dialysate ± L-2-oxothiazolodine-4-carboxylic acid 1 mmol/L (OTZ). OTZ was used as the precursor for the synthesis of glutathione in these cells. Dialysate accelerated senescence of the mesothelial cells as reflected by elongation of their population doubling time, reduced expression of KI-67 gene, and increased β-galactosidase activity. Also, expression of the genes regulating the production of the inflammatory mediators (interleukin-6, monocyte chemoattractant protein-1, metalloproteinase-2, hyaluronan), proangiogenic (VEGF) and profibrotic (fibronectin) factors was increased in that group. At the same time, these cells secreted more inflammatory mediators. Simultaneous treatment of the cells with the dialysate and OTZ slowed down their senescence, whose intensity was similar to that in the control group. The results presented in this manuscript prove that the intraperitoneal inflammatory reaction induced by repeated infusions of the dialysis fluid accelerates the senescence of the mesothelial cells, which may result in fibrosis and neoangiogenesis within the peritoneum. Simultaneous supplementation of the cells with a glutathione precursor (OTZ) may prevent the development of these pathological changes.

MeSH terms

  • Cells, Cultured
  • Cellular Senescence / drug effects*
  • Dialysis Solutions / metabolism
  • Glutathione / metabolism
  • Humans
  • Inflammation / etiology
  • Inflammation / prevention & control
  • Inflammation Mediators / metabolism
  • Peritoneal Dialysis / adverse effects
  • Peritoneal Dialysis / methods*
  • Peritoneum / cytology
  • Peritoneum / drug effects*
  • Pyrrolidonecarboxylic Acid / pharmacology*
  • Thiazolidines / pharmacology*

Substances

  • Dialysis Solutions
  • Inflammation Mediators
  • Thiazolidines
  • Glutathione
  • Pyrrolidonecarboxylic Acid
  • 2-oxothiazolidine-4-carboxylic acid